Rezultati pretraživanja
  1. prije 3 sata
  2. prije 8 sati

    : New SEC Filing for CNAT: Form SC 13G/A (No. 0001193125-20-025220):

  3. Conatus Pharmaceuticals vs. Oramed Pharmaceuticals Critical Review

  4. 4. velj
  5. 2. velj
  6. 31. sij

    Short sale volume (not short interest) for at 2020-01-30 is 31%. 28% 53% 74% 80%

  7. 31. sij
  8. 31. sij
  9. 30. sij
  10. 29. sij

    Intraday DOWN alert max move results: 10% 9% 6% 3% 8% 10% 12% 13%

  11. 29. sij
  12. 29. sij

    WATCHLIST FOR THIS AFTERNOON

  13. 29. sij
  14. 29. sij
  15. 28. sij

    Biotech updates 01/28: capital injection +74% offering -10% AH PDUFA Nov 15 PDUFA May 26 & reverse mergers offering data mid-'20 +21% +45% AH Pipeline updates

  16. 28. sij

    -30% after merger news still up $0.08 after merger news but annual return -75% Congrats longs 💩

  17. 28. sij

    $1+ merger value this seems a steal here 50c

  18. 28. sij

    so long to this trash heap Another SA contributor favorite, I'll never understand why

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.